August 2016

The XXIV EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2016) will be organised by the Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry, on behalf of the European Federation for Medicinal Chemistry (EFMC).

EFMC is the main organisation for European Medicinal Chemistry community with 25 member societies and about 7.500 members. Its biennial EFMC-ISMC is a key symposium in its field and attracts traditionally between 1200 and 1400 participants, from industry and academia. Recent EFMC-ISMC meetings have taken place in Denmark (Copenhagen/Malmö, 2004), Turkey (Istanbul, 2006), Austria (Vienna, 2008), Belgium (Brussels, 2010), Germany (Berlin, 2012) and Portugal (Lisbon, 2014).

The 2016 edition will continue the tradition established by these biennial symposia of covering drug discovery advances in major therapeutic areas, including the treatment of pain, CNS disorders, anti-infectives, ophthalmology, cardiovascular diseases and oncology. EFMC-ISMC 2016 will present the most recent advances in lead identification and optimization strategies, drug design and profiling technologies. The impact of biomarkers and imaging at the interfaces between chemistry, biology and experimental medicine will be illustrated. Particular emphasis will be put on first time disclosures, recent highlights in medicinal chemistry, and the impact of novel organic synthesis in drug discovery.

The symposium will take place at the Manchester Central Convention Complex from August 28 - September 1, 2016.

The XXIV EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2016) will be organised by the Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry, on behalf of the European Federation for Medicinal Chemistry (EFMC).

EFMC is the main organisation for European Medicinal Chemistry community with 25 member societies and about 7.500 members. Its biennial EFMC-ISMC is a key symposium in its field and attracts traditionally between 1200 and 1400 participants, from industry and academia. Recent EFMC-ISMC meetings have taken place in Denmark (Copenhagen/Malmö, 2004), Turkey (Istanbul, 2006), Austria (Vienna, 2008), Belgium (Brussels, 2010), Germany (Berlin, 2012) and Portugal (Lisbon, 2014).

The 2016 edition will continue the tradition established by these biennial symposia of covering drug discovery advances in major therapeutic areas, including the treatment of pain, CNS disorders, anti-infectives, ophthalmology, cardiovascular diseases and oncology. EFMC-ISMC 2016 will present the most recent advances in lead identification and optimization strategies, drug design and profiling technologies. The impact of biomarkers and imaging at the interfaces between chemistry, biology and experimental medicine will be illustrated. Particular emphasis will be put on first time disclosures, recent highlights in medicinal chemistry, and the impact of novel organic synthesis in drug discovery.

The symposium will take place at the Manchester Central Convention Complex from August 28 - September 1, 2016.

The XXIV EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2016) will be organised by the Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry, on behalf of the European Federation for Medicinal Chemistry (EFMC).

EFMC is the main organisation for European Medicinal Chemistry community with 25 member societies and about 7.500 members. Its biennial EFMC-ISMC is a key symposium in its field and attracts traditionally between 1200 and 1400 participants, from industry and academia. Recent EFMC-ISMC meetings have taken place in Denmark (Copenhagen/Malmö, 2004), Turkey (Istanbul, 2006), Austria (Vienna, 2008), Belgium (Brussels, 2010), Germany (Berlin, 2012) and Portugal (Lisbon, 2014).

The 2016 edition will continue the tradition established by these biennial symposia of covering drug discovery advances in major therapeutic areas, including the treatment of pain, CNS disorders, anti-infectives, ophthalmology, cardiovascular diseases and oncology. EFMC-ISMC 2016 will present the most recent advances in lead identification and optimization strategies, drug design and profiling technologies. The impact of biomarkers and imaging at the interfaces between chemistry, biology and experimental medicine will be illustrated. Particular emphasis will be put on first time disclosures, recent highlights in medicinal chemistry, and the impact of novel organic synthesis in drug discovery.

The symposium will take place at the Manchester Central Convention Complex from August 28 - September 1, 2016.

The XXIV EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2016) will be organised by the Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry, on behalf of the European Federation for Medicinal Chemistry (EFMC).

EFMC is the main organisation for European Medicinal Chemistry community with 25 member societies and about 7.500 members. Its biennial EFMC-ISMC is a key symposium in its field and attracts traditionally between 1200 and 1400 participants, from industry and academia. Recent EFMC-ISMC meetings have taken place in Denmark (Copenhagen/Malmö, 2004), Turkey (Istanbul, 2006), Austria (Vienna, 2008), Belgium (Brussels, 2010), Germany (Berlin, 2012) and Portugal (Lisbon, 2014).

The 2016 edition will continue the tradition established by these biennial symposia of covering drug discovery advances in major therapeutic areas, including the treatment of pain, CNS disorders, anti-infectives, ophthalmology, cardiovascular diseases and oncology. EFMC-ISMC 2016 will present the most recent advances in lead identification and optimization strategies, drug design and profiling technologies. The impact of biomarkers and imaging at the interfaces between chemistry, biology and experimental medicine will be illustrated. Particular emphasis will be put on first time disclosures, recent highlights in medicinal chemistry, and the impact of novel organic synthesis in drug discovery.

The symposium will take place at the Manchester Central Convention Complex from August 28 - September 1, 2016.